Professor George Fink,
Russian adenovirus anti-Covid-19 vaccine Published in thge Lancet 4-9-20
Russian adenovirus anti-Covid-19 vaccine Published in thge Lancet 4-9-20
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored #COVID-19 #vaccine: a dose-escalation, open…
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31208-3/fulltext
In this time of crisis the cheap hype would not help at all. You need to proceed in a scientific way to prove it. Those…
বাংলাদেশে কি COVID-19 এর ভ্যাক্সিন তৈরি হয়েছে? গ্লোব বায়োটেক লিমিটেড নামক একটি সংস্থা দাবি করেছে, বাংলাদেশে প্রথমবারের মতো কোভ…
初めて一流紙に登場したCOVID19ワクチンは中国CanSino Biologics製。Ad5べクターでスパイクタンパクを発現させるもの。195人へのP1はtolerable and immunogenic。トップ集団を形成中:江蘇CDC。 https:…
Did you know that severe adverse reactions were reported in 8% of participants in a Chinese COVID-19 vaccine trial? “The Ad5…
Nach einem US-amerikanischen hat jetzt auch ein chinesischer Impfstoffentwickler erste klinische Ergebnisse zu einer Vakzine…
The Ad5 vectored COVID-19 vaccine is tolerable and immunogenic at 28 days post-vaccination. Humoral responses against SARS-CoV-2…
#novocoronavírus Pesquisadores chineses testam uma nova vacina contra a Covid-19, a Ad5-nCoV, em um ensaio clínico, realizado…
🛑Al alcanzar el ensayo clínico de fase 1 de una potencial vacuna de COVID-19, esta muestra ser segura e inducir una respuesta…
Did you know that severe adverse reactions were reported in 8% of participants in a Chinese COVID-19 vaccine trial? “The Ad5…
RUDIMENTI DI LIGHT…
بدأ تجربة لقاحين إثنين لفيروس كورونا عافاكم الله والنتائج إيجابية https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736…
دكتور علاء الدين السبيعي نتائج التجربة الطبية الأولى للقاح كورونا على البشر والتي تحدثت عنها في بوست سابق ، وهو لقاح ال mRNA الذ…
First human trial of COVID-19 vaccine finds it is safe and induces rapid immune…
The first human trial of COVID-19 vaccine finds it is safe and induces rapid immune response. https://www.thelancet.com/journals…
Covid vaccine passes phase 1 human trial : https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31208-3/fulltext…
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-la…
Estudo publicado na revista Lancet diz que vacina é…
The first human trial of a COVID-19 vaccine finds that it is safe, well-tolerated, and induces a rapid immune response: “These…
NEW | First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response | Research in The…
First human trial of COVID-19 vaccine finds it is safe and induces rapid immune…
NEW | First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response | Research in The…
First human trial of COVID-19 vaccine finds it is safe and induces rapid immune…
First human trial of COVID-19 vaccine finds it is safe and induces rapid immune…
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-la…
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-la…
⚠️⚠️⚠️
More trials/research needed but a cause for optimism perhaps. The Lancet @TheLancet NEW Research—First human trial of #COVID19…
Terrific, readable analysis by Dr. Emily Willingham.
#covid19 #vaccine #lancet First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response | Research…
NEW | First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response | Research in The…
NEW | First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response | Research in The…
NEW | First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response | Research in The…
NEW | First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response | Research in The…